<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="Isotretinoin" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">livertox</book-id>
    <book-title-group>
      <book-title>LiverTox</book-title>
      <subtitle>Clinical and Research Information on Drug-Induced Liver Injury</subtitle>
    </book-title-group>
    <pub-date date-type="pubr" publication-format="electronic">
      <year>2012</year>
    </pub-date>
    <publisher>
      <publisher-name>National Institute of Diabetes and Digestive and Kidney Diseases</publisher-name>
      <publisher-loc>Bethesda (MD)</publisher-loc>
    </publisher>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">Isotretinoin</book-part-id>
      <title-group>
        <title>Isotretinoin</title>
      </title-group>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>11</month>
          <year>2020</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="livertox">LiverTox: Clinical and Research Information on Drug-Induced Liver Injury</related-object>
      <related-object link-type="previous-part-link" source-id="livertox" document-id="Isoniazid" document-type="chapter">Isoniazid</related-object>
      <related-object link-type="next-part-link" source-id="livertox" document-id="Isradipine" document-type="chapter">Isradipine</related-object>
    </book-part-meta>
    <body>
      <sec id="Isotretinoin.OVERVIEW">
        <title>OVERVIEW</title>
        <sec id="Isotretinoin.Introduction" sec-type="pubmed-excerpt">
          <title>Introduction</title>
          <p>Isotretinoin is a retinoid and vitamin A derivative used in the treatment of severe acne and some forms of skin, head and neck cancer. Isotretinoin, like many retinoids, can lead to increase in serum aminotransferase levels, but, unlike acitretin and etretinate, isotretinoin has not been clearly implicated in cases of clinically apparent acute liver injury with jaundice.</p>
        </sec>
        <sec id="Isotretinoin.Background">
          <title>Background</title>
          <p>Isotretinoin (eye" soe tret' i noyn), also known as 13-cis-retinoic acid, is an aromatic retinoid similar to vitamin A which is effective in treating refractory nodular acne and other disorders of keratinization. Unlike vitamin A, isotretinoin is not stored in the liver and is not associated with many of the toxic effects of high dose vitamin A therapy. Its mechanism of action in acne is believed to be mediated by activation of retinoic acid and retinoid X receptors, which regulate gene expression important in normalizing cell growth and differentiation. Isotretinoin is considered a second generation retinoid and its relative lack of receptor specificity accounts for its adverse side effects. All oral retinoids are potent teratogens and must be avoided or used with extreme caution in women of childbearing potential. Isotretinoin was approved for use in acne in the United States in 1982 and it is currently used, but only under strict requirements for monitoring and birth control. Indications are limited to severe nodular acne in a patient who has failed to respond to conventional therapy including systemic antibiotics. Isotretinoin is available in generic forms and under several brand names (Absorica, Amnesteem, Claravis, Myorisan, Sotret, Zenatane and previously Accutane) in capsules of 10, 20, 30 and 40 mg, the usual dose in adults being 0.5 to 2.0 mg/kg per day given in two divided doses for 15 to 20 weeks. Higher doses have been used in treatment of head and neck cancers. Side effects are common and include dry skin, nose bleeds, conjunctivitis and hair loss. Use of isotretinoin has also been linked to worsening of hyperlipidemia, hyperostosis, vision and hearing loss, pancreatitis, pseudotumor cerebri, birth defects, depression and suicide.</p>
        </sec>
        <sec id="Isotretinoin.Hepatotoxicity">
          <title>Hepatotoxicity</title>
          <p>Liver test abnormalities occur in up to 15% of patients on isotretinoin, although marked elevations above three times the upper limit of normal or requiring drug discontinuation are rare (&#x0003c;1%). The liver test abnormalities are typically asymptomatic and transient and can resolve even with continuing therapy. Clinically apparent liver injury due to isotretinoin is exceedingly rare. The acute liver injury with signs of hypersensitivity that occurs with etretinate and acitretin has not been described with isotretinoin therapy. Vitamin A-like effects on the liver with accumulation of lipids in nonparenchymal stellate cells has been described in rare patients on isotretinoin therapy, but the role of supplementary use of vitamin A in these cases was not ruled out. Thus, the majority of reported cases of liver injury attributed to isotretinoin have been anicteric with no or minimal symptoms. However, the lack of reports of more severe hepatitis with jaundice may be due to the close monitoring and early discontinuation of isotretinoin which is required in the use of this agent for acne.</p>
          <p>Likelihood score: D (possible rare cause of clinically apparent liver injury).</p>
        </sec>
        <sec id="Isotretinoin.Mechanism_of_Injury">
          <title>Mechanism of Injury</title>
          <p>The mechanism by which isotretinoin causes serum aminotransferase elevations is not known, but it may represent a direct toxic effect, in that it appears to be more frequent with higher dose therapy.</p>
        </sec>
        <sec id="Isotretinoin.Outcome_and_Management">
          <title>Outcome and Management</title>
          <p>Monitoring of liver tests is recommended for patients receiving isotretinoin at regular intervals. The serum aminotransferase elevations that occur during treatment are usually self-limited and do not always require dose modification or discontinuation of therapy. However, de novo elevations in serum aminotransferase levels of more than 5 times the upper limit of normal should prompt at least temporary discontinuation, particularly if confirmed on a second sample or if accompanied by symptoms or jaundice. Patients with acitretin or etretinate associated acute liver injury have been found to tolerate isotretinoin without recurrence of liver injury, although isotretinoin is not approved and may not be as effective as acitretin in treating psoriasis.</p>
          <p>Drug Class: Dermatologic Agents; <related-object link-type="booklink" source-id="livertox" document-id="Vitamins" document-type="chapter">Vitamins</related-object></p>
          <p>Other Drugs in the Subclass:</p>
          <list list-type="bullet">
            <list-item>
              <p>
                <related-object link-type="booklink" source-id="livertox" document-id="VitaminA" document-type="chapter">Vitamin A</related-object>
              </p>
            </list-item>
            <list-item>
              <p>
                <related-object link-type="booklink" source-id="livertox" document-id="Retinoids" document-type="chapter">Retinoids</related-object>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p><related-object link-type="booklink" source-id="livertox" document-id="Acitretin" document-type="chapter">Acitretin</related-object>, <related-object link-type="booklink" source-id="livertox" document-id="Acitretin" document-type="chapter">Etretinate</related-object></p>
                </list-item>
                <list-item>
                  <p>
                    <related-object link-type="booklink" source-id="livertox" document-id="Bexarotene" document-type="chapter">Bexarotene</related-object>
                  </p>
                </list-item>
              </list>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="Isotretinoin.CASE_REPORT">
        <title>CASE REPORT</title>
        <sec id="Isotretinoin.Case_1_Acute_anicteric_hepa">
          <title>Case 1. Acute anicteric hepatitis with autoimmune features due to isotretinoin.(<xref ref-type="bibr" rid="Isotretinoin.REF.1">1</xref>)</title>
          <p>A 16 year old adolescent female was found to have serum aminotransferase elevations 11 weeks after starting isotretinoin for severe acne. She had no history of liver disease, drug allergies, risk factors for viral hepatitis or alcohol use. Her past medical history included Hashimoto thyroiditis and hypothyroidism for which she took levothyroxine (50 mg daily). She was taking no other medications including over-the-counter products and herbal supplements. She had no symptoms of liver disease and the elevations were identified during routine monitoring of the isotretinoin therapy. Physical examination showed no evidence of hepatomegaly, abdominal tenderness or jaundice. Laboratory tests showed a serum ALT of 853 [22.4 times ULN], AST 501 U/L [12.5 times ULN], alkaline phosphatase 48 U/L [normal &#x0003c;340], and bilirubin 0.3 mg/dL [direct 0.10]. The R ratio was 22. The following week the ALT had risen to 1199 U/L and AST to 756 U/L, and isotretinoin was stopped (Table). Serum bilirubin remained normal, albumin was 4.3 g/dL, globulins 2.9 g/dL and INR 1.1. Tests for hepatitis A, B, C and E were negative. While serum SMA was negative, ANA was positive in a titer of 1:160 and IgG was mildly elevated [1659 mg/dL, normal 700-1550 mg/dL]. Abdominal ultrasonography showed no evidence of biliary obstruction and no organomegaly or hepatic masses. A liver biopsy showed focal hepatocyte degeneration and parenchymal lymphocytic infiltration as well as mild portal inflammation and mild interface hepatitis. Because of the possibility of autoimmune hepatitis, she was started on prednisone (40 mg daily) to which azathioprine was added 2 weeks later. The serum aminotransferase levels rapidly improved and were normal 6 weeks after starting therapy. The prednisone was gradually reduced in dosage and eventually discontinued. The liver tests remained normal thereafter; isotretinoin was not restarted.</p>
          <sec id="Isotretinoin.Key_Points">
            <title>Key Points</title>
            <table-wrap id="Isotretinoin.Tc" orientation="portrait" position="anchor">
              <table frame="hsides" rules="groups">
                <tbody>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Medication:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_1_1" valign="top" align="left" rowspan="1" colspan="1">Isotretinoin (20 mg twice daily)</td>
                  </tr>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_2_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Pattern:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_2_1" valign="top" align="left" rowspan="1" colspan="1">Hepatocellular (peak R=32)</td>
                  </tr>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_3_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Severity:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_3_1" valign="top" align="left" rowspan="1" colspan="1">1+ (anicteric)</td>
                  </tr>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_4_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Latency:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_4_1" valign="top" align="left" rowspan="1" colspan="1">11 weeks</td>
                  </tr>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_5_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Recovery:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_5_1" valign="top" align="left" rowspan="1" colspan="1">8 weeks</td>
                  </tr>
                  <tr>
                    <th id="hd_b_Isotretinoin.Tc_1_1_6_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Other medications:</th>
                    <td headers="hd_b_Isotretinoin.Tc_1_1_6_1" valign="top" align="left" rowspan="1" colspan="1">Levothyroxine</td>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
          <sec id="Isotretinoin.Laboratory_Values">
            <title>Laboratory Values</title>
            <table-wrap id="Isotretinoin.Td" orientation="portrait" position="anchor">
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_1" valign="top" align="center" scope="col" rowspan="1" colspan="1">Time After<break/>Starting</th>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_2" valign="top" align="center" scope="col" rowspan="1" colspan="1">Time After<break/>Stopping</th>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_3" valign="top" align="center" scope="col" rowspan="1" colspan="1">ALT<break/>(U/L)</th>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_4" valign="top" align="center" scope="col" rowspan="1" colspan="1">Alk P<break/>(U/L)</th>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_5" valign="top" align="center" scope="col" rowspan="1" colspan="1">Bilirubin<break/>(mg/dL)</th>
                    <th id="hd_h_Isotretinoin.Td_1_1_1_6" valign="top" align="center" scope="col" rowspan="1" colspan="1">Comments</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Pre</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">26</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">43</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.4</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Isotretinoin started</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">11 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">853</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">48</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Asymptomatic</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">12 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">0</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">1199</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">114</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.4</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Isotretinoin stopped</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">14 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">327</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">105</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Prednisone 40 mg/d</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">15 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">123</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">78</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Azathioprine added</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">17 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">5 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">68</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">52</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Prednisone dose reduced</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">19 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">7 weeks</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">41</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">29</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">5 months</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2 months</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">40</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">23</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.4</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Prednisone 5 mg/d</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">6 months</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3 months</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">24</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">19</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.3</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">1.5 years</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">1 year</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">23</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">41</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.7</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">No Pred or Azathioprine</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">2 years</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">2 years</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">16</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">40</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.4</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">3 years</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">3 years</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">25</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">31</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">0.4</td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                  <tr>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_1 hd_h_Isotretinoin.Td_1_1_1_2" valign="middle" colspan="2" align="center" scope="row" rowspan="1">
                      <bold>Normal Values</bold>
                    </td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_3" valign="middle" align="center" rowspan="1" colspan="1">
                      <bold>&#x0003c;38</bold>
                    </td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_4" valign="middle" align="center" rowspan="1" colspan="1">
                      <bold>&#x0003c;340</bold>
                    </td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_5" valign="middle" align="center" rowspan="1" colspan="1">
                      <bold>&#x0003c;1.2</bold>
                    </td>
                    <td headers="hd_h_Isotretinoin.Td_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1"/>
                  </tr>
                </tbody>
              </table>
            </table-wrap>
          </sec>
          <sec id="Isotretinoin.Comment">
            <title>Comment</title>
            <p>An acute anicteric hepatitis arose during isotretinoin therapy in an adolescent girl with acne and a history of autoimmune thyroid disease. The hepatitis was asymptomatic, but ALT levels rose to 32 times ULN and the drug was stopped. Testing revealed a high titer of ANA and mild immunoglobulin elevations prompting a liver biopsy that was read as compatible with autoimmune hepatitis. She was treated with prednisone and azathioprine and liver tests fell to normal within 6 to 8 weeks. The dose of prednisone was gradually decreased and both prednisone and azathioprine were subsequently discontinued. She was followed carefully thereafter, and liver tests remained normal. This case nicely demonstrates the marked serum aminotransferase elevations that can occur during isotretinoin therapy. Unique in this case was the accompanying autoimmune features which led to use of immunosuppression. Importantly, prednisone and azathioprine were subsequently reduced in dose and then discontinued. Liver tests remained normal indicating that the injury was probably drug induced liver injury with autoimmune features rather than spontaneous autoimmune hepatitis. [Addition details and test results kindly provided by Dr. Patricia Guzman.]</p>
          </sec>
        </sec>
      </sec>
      <sec id="Isotretinoin.PRODUCT_INFORMATION">
        <title>PRODUCT INFORMATION</title>
        <p>
          <bold>REPRESENTATIVE TRADE NAMES</bold>
        </p>
        <p>Isotretinoin &#x02013; Generic, Absorica&#x000ae;, Claravis&#x000ae;, Zenatane&#x000ae;</p>
        <p>
          <bold>DRUG CLASS</bold>
        </p>
        <p>Dermatologic Agents</p>
        <p>
          <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&#x00026;query=Isotretinoin">COMPLETE LABELING</ext-link>
        </p>
        <p>Product labeling at DailyMed, National Library of Medicine, NIH</p>
      </sec>
      <sec id="Isotretinoin.CHEMICAL_FORMULA_AND_STRUCT">
        <title>CHEMICAL FORMULA AND STRUCTURE</title>
        <table-wrap id="Isotretinoin.Te" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_Isotretinoin.Te_1_1_1_1" valign="top" align="left" scope="col" rowspan="1" colspan="1">DRUG</th>
                <th id="hd_h_Isotretinoin.Te_1_1_1_2" valign="top" align="left" scope="col" rowspan="1" colspan="1">CAS REGISTRY NUMBER</th>
                <th id="hd_h_Isotretinoin.Te_1_1_1_3" valign="top" align="left" scope="col" rowspan="1" colspan="1">MOLECULAR FORMULA</th>
                <th id="hd_h_Isotretinoin.Te_1_1_1_4" valign="top" align="left" scope="col" rowspan="1" colspan="1">STRUCTURE</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_Isotretinoin.Te_1_1_1_1" valign="top" align="left" scope="row" rowspan="1" colspan="1">Isotretinoin</td>
                <td headers="hd_h_Isotretinoin.Te_1_1_1_2" valign="top" align="left" rowspan="1" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pubchem" xlink:href="sid://134985730">4759-48-2</ext-link>
                </td>
                <td headers="hd_h_Isotretinoin.Te_1_1_1_3" valign="top" align="left" rowspan="1" colspan="1">C20-H28-O2</td>
                <td headers="hd_h_Isotretinoin.Te_1_1_1_4" valign="top" align="left" rowspan="1" colspan="1">
                  <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="Isotretinoin-Image001.jpg" mime-subtype="jpeg"/>
                </td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="Isotretinoin.CITED_REFERENCES">
        <title>CITED REFERENCES</title>
        <ref-list id="Isotretinoin.CITED_REFERENCES.reflist0">
          <ref id="Isotretinoin.REF.1">
            <label>1</label>
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Guzman Rojas</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Gallegos Lopez</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Ciliotta Chehade</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Scavino</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Morales</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Tagle</surname>
                  <given-names>M.</given-names>
                </name>
              </person-group>
              <comment>[Autoimmune hepatitis induced by isotretionine]</comment>
              <source>Rev Gastroenterol Peru.</source>
              <year>2016</year>
              <volume>36</volume>
              <fpage>86</fpage>
              <lpage>9</lpage>
              <comment>Spanish.</comment>
              <pub-id pub-id-type="pmid">27131947</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
      <sec id="Isotretinoin.ANNOTATED_BIBLIOGRAPHY">
        <title>ANNOTATED BIBLIOGRAPHY</title>
        <p>References updated: 10 November 2020</p>
        <ref-list id="Isotretinoin.ANNOTATED_BIBLIOGRAPHY.reflist0">
          <ref id="Isotretinoin.REF.zimmerman.1999">
            <mixed-citation publication-type="book">Zimmerman HJ. Vitamin A(retinol). Drugs used in dermatotherapy. In, Zimmerman HJ. Hepatotoxicity: the adverse effects of drugs and other chemicals on the liver. 2nd ed. Philadelphia: Lippincott, 1999, pp. 727-9.<annotation><p><italic toggle="yes">(Expert review of hepatotoxicity of vitamin A and the retinoids published in 1999; mentions two published reports of acute necrosis due to acitretin).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Isotretinoin.REF.liu.2007">
            <mixed-citation publication-type="book">Liu LU, Schiano TD. Vitamin A (retinol). Hepatotoxicity of herbal medications, vitamins and natural hepatotoxins. In, Kaplowitz N, DeLeve LD, eds. Drug-induced liver disease. 2nd ed. New York: Informa Healthcare USA, 2007, pp. 744-6.<annotation><p><italic toggle="yes">(Review of vitamin A and retinoid hepatotoxicity published in 2007).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Isotretinoin.REF.sewell.2018">
            <mixed-citation publication-type="book">Sewell MJ, Burkhart C, Morrell D. Dermatological pharmacology. In, Brunton LL, Hilal-Dandan R, Knollman BC, eds. Goodman &#x00026; Gilman's the pharmacological basis of therapeutics. 13th ed. New York: McGraw-Hill, 2018, pp. 1271-96.<annotation><p><italic toggle="yes">(Textbook of pharmacology and therapeutics).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Isotretinoin.REF.peck.1979.329">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Peck</surname>
                  <given-names>GL</given-names>
                </name>
                <name name-style="western">
                  <surname>Olsen</surname>
                  <given-names>TG</given-names>
                </name>
                <name name-style="western">
                  <surname>Yoder</surname>
                  <given-names>FW</given-names>
                </name>
                <name name-style="western">
                  <surname>Strauss</surname>
                  <given-names>JS</given-names>
                </name>
                <name name-style="western">
                  <surname>Downing</surname>
                  <given-names>DT</given-names>
                </name>
                <name name-style="western">
                  <surname>Pandya</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Butkus</surname>
                  <given-names>D</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid.</article-title>
              <source>N Engl J Med</source>
              <year>1979</year>
              <volume>300</volume>
              <fpage>329</fpage>
              <lpage>33</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Initial report on use of isotretinoin for severe acne mentions that mild and transient ALT elevations occurred in one of the 14 patients treated for 4 months).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">153472</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.thune.1980.405">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Thune</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Mork</surname>
                  <given-names>NJ</given-names>
                </name>
              </person-group>
              <article-title>A case of centrolobular toxic necrosis of the liver due to aromatic retinoid--Tigason (Ro-10-9359).</article-title>
              <source>Dermatologica</source>
              <year>1980</year>
              <volume>160</volume>
              <fpage>405</fpage>
              <lpage>8</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(54 year old woman with ichthyosis developed fatigue 2-3 months after starting etretinate [peak bilirubin 2.6 mg/dL, ALT 1260 U/L, Alk P 350 U/L], biopsy showing centrolobular necrosis, with slow resolution over the next 6 months).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">7389973</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.peck.1982.735">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Peck</surname>
                  <given-names>GL</given-names>
                </name>
                <name name-style="western">
                  <surname>Olsen</surname>
                  <given-names>TG</given-names>
                </name>
                <name name-style="western">
                  <surname>Butkus</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Pandya</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Arnaud-Battandier</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Gross</surname>
                  <given-names>EG</given-names>
                </name>
                <name name-style="western">
                  <surname>Windhorst</surname>
                  <given-names>DB</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Isotretinoin versus placebo in the treatment of cystic acne. A randomized double-blind study.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>1982</year>
              <volume>6</volume>
              <supplement>Suppl</supplement>
              <fpage>735</fpage>
              <lpage>45</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Controlled trial of 4 months of isotretinoin in 33 patients with severe acne showed dramatic therapeutic effect; side effects were dry skin, eyes and nasal membranes and dermatitis; ALT elevations occurred in 3 patients [10%], but levels returned to normal despite continuing and no patient stopped therapy because of side effects).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6461677</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.olson.1983.290">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Olson</surname>
                  <given-names>JA</given-names>
                </name>
              </person-group>
              <article-title>Adverse effects of large doses of vitamin A and retinoids.</article-title>
              <source>Semin Oncol</source>
              <year>1983</year>
              <volume>10</volume>
              <fpage>290</fpage>
              <lpage>3</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of retinoids and vitamin A which do not share same toxicity, but usually have a low therapeutic-toxic index).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6364354</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.hennes.1984.209">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Hennes</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Mack</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Schell</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Vogt</surname>
                  <given-names>HJ</given-names>
                </name>
              </person-group>
              <article-title>13-cis-retinoic acid in conglobate acne. A follow-up study of 14 trial centers.</article-title>
              <source>Arch Dermatol Res</source>
              <year>1984</year>
              <volume>276</volume>
              <fpage>209</fpage>
              <lpage>15</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 87 patients treated with isotretinoin for severe acne monitored for 12-21 months, sustained remissions occurred in 81% and all side effects resolved within 3 months of stopping; no mention of hepatotoxicity).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6236757</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.ward.1984.6">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ward</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Brogden</surname>
                  <given-names>RN</given-names>
                </name>
                <name name-style="western">
                  <surname>Heel</surname>
                  <given-names>RC</given-names>
                </name>
                <name name-style="western">
                  <surname>Speight</surname>
                  <given-names>TM</given-names>
                </name>
                <name name-style="western">
                  <surname>Avery</surname>
                  <given-names>GS</given-names>
                </name>
              </person-group>
              <article-title>Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders.</article-title>
              <source>Drugs</source>
              <year>1984</year>
              <volume>28</volume>
              <fpage>6</fpage>
              <lpage>37</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of pharmacology, efficacy and safety of isotretinoin: elevations in liver tests occur in 10% of patients, "although these changes rarely reach statistical or clinical significant levels").</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6235105</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.marsden.1984.243">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Marsden</surname>
                  <given-names>JR</given-names>
                </name>
                <name name-style="western">
                  <surname>Trinick</surname>
                  <given-names>TR</given-names>
                </name>
                <name name-style="western">
                  <surname>Laker</surname>
                  <given-names>MF</given-names>
                </name>
                <name name-style="western">
                  <surname>Shuster</surname>
                  <given-names>S</given-names>
                </name>
              </person-group>
              <article-title>Effects of isotretinoin on serum lipids and lipoproteins, liver and thyroid function.</article-title>
              <source>Clin Chim Acta</source>
              <year>1984</year>
              <volume>143</volume>
              <fpage>243</fpage>
              <lpage>51</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(7 patients with rosacea were treated with isotretinoin for 16 weeks; average serum AST levels increased from 17 to 24 U/L and Alk P from 69 to 81 U/L, while bilirubin levels fell and no patient developed clinically apparent liver injury).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6238729</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.strauss.1984.490">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Strauss</surname>
                  <given-names>JS</given-names>
                </name>
                <name name-style="western">
                  <surname>Rapini</surname>
                  <given-names>RP</given-names>
                </name>
                <name name-style="western">
                  <surname>Shalita</surname>
                  <given-names>AR</given-names>
                </name>
                <name name-style="western">
                  <surname>Konecky</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Pochi</surname>
                  <given-names>PE</given-names>
                </name>
                <name name-style="western">
                  <surname>Comite</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Exner</surname>
                  <given-names>JH</given-names>
                </name>
              </person-group>
              <article-title>Isotretinoin therapy for acne: results of a multicenter dose-response study.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>1984</year>
              <volume>10</volume>
              <fpage>490</fpage>
              <lpage>6</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(150 patients with nodulocystic acne were treated with one of 3 doses of isotretinoin [0.1, 0.5 or 1.0 mg/kg/day] for 20 weeks; side effects were common [dry skin, nosebleeds, hair loss, headache], mean ALT and AST values increased slightly in the highest dose group, and AST increases occurred in 15-18% of patients, but did not lead to dose modification or clinical symptoms).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">6233335</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.heller.1985.1129">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Heller</surname>
                  <given-names>EH</given-names>
                </name>
                <name name-style="western">
                  <surname>Shiffman</surname>
                  <given-names>NJ</given-names>
                </name>
              </person-group>
              <article-title>Synthetic retinoids in dermatology.</article-title>
              <source>Can Med Assoc J</source>
              <year>1985</year>
              <volume>132</volume>
              <fpage>1129</fpage>
              <lpage>36</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Discussion of two synthetic analogues of vitamin A introduced into dermatology: isotretinoin [used in acne] and etretinate [used in psoriasis]; these retinoids are less toxic than vitamin A and not stored in the liver, although they are metabolized there; minor liver test abnormalities may arise during therapy, but rarely required dose modification).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">3158386</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.vahlquist.1985.359">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Vahlquist</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>L&#x000f6;L, Nordlinder H, Rollman O, Vahlquist C. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis.</article-title>
              <source>Acta Derm Venereol</source>
              <year>1985</year>
              <volume>65</volume>
              <fpage>359</fpage>
              <lpage>62</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(64 year old woman was found to have abnormal liver tests 5 months after starting etretinate [bilirubin 0.7 mg/dL, ALT 950 U/L, Alk P 402 U/L], liver biopsy showing hepatitis without steatosis, resolving with stopping and prednisone therapy, recurring upon rechallenge, but not when isotretinoin was started which was less effective for the psoriasis).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">2413699</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.yob.1987.1375">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Yob</surname>
                  <given-names>EH</given-names>
                </name>
                <name name-style="western">
                  <surname>Pochi</surname>
                  <given-names>PE</given-names>
                </name>
              </person-group>
              <article-title>Side effects and long-term toxicity of synthetic retinoids.</article-title>
              <source>Arch Dermatol</source>
              <year>1987</year>
              <volume>123</volume>
              <fpage>1375</fpage>
              <lpage>8</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Retinoids are modifications of vitamin A molecule and are not stored in the liver; hepatotoxicity of retinoids is different from that of vitamin A, usually arising within first 1-2 months and having features of hypersensitivity).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">3310911</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.david.1988.273">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>David</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Hodak</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Lowe</surname>
                  <given-names>NJ</given-names>
                </name>
              </person-group>
              <article-title>Adverse effects of retinoids.</article-title>
              <source>Med Toxicol Adverse Drug Exp</source>
              <year>1988</year>
              <volume>3</volume>
              <fpage>273</fpage>
              <lpage>88</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of pharmacology, clinical effectiveness and low dose, long term toxicities of the retinoids; states that therapy usually has little effect on ALT or bilirubin levels).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">3054426</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.roenigk.1988.199">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Roenigk</surname>
                  <given-names>HH</given-names>
                  <suffix>Jr</suffix>
                </name>
              </person-group>
              <article-title>Liver toxicity of retinoid therapy.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>1988</year>
              <volume>19</volume>
              <issue>1 Pt 2</issue>
              <fpage>199</fpage>
              <lpage>208</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of hepatotoxicity of vitamin A and the retinoids).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">3045164</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.roenigk.1989.145">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Roenigk</surname>
                  <given-names>HH</given-names>
                  <suffix>Jr</suffix>
                </name>
              </person-group>
              <article-title>Liver toxicity of retinoid therapy.</article-title>
              <source>Pharmacol Ther</source>
              <year>1989</year>
              <volume>40</volume>
              <fpage>145</fpage>
              <lpage>55</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of toxicity of retinoids including description of liver biopsy results described by Glazer [1982]).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">2645587</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.fallon.1990.334">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Fallon</surname>
                  <given-names>MB</given-names>
                </name>
                <name name-style="western">
                  <surname>Boyer</surname>
                  <given-names>JL</given-names>
                </name>
              </person-group>
              <article-title>Hepatic toxicity of vitamin A and synthetic retinoids.</article-title>
              <source>J Gastroenterol Hepatol</source>
              <year>1990</year>
              <volume>5</volume>
              <fpage>334</fpage>
              <lpage>42</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of liver injury due to hypervitaminosis A and retinoids identified 18 reports of vitamin A hepatotoxicity in the English literature, patient ages 6 to 63 years, presenting with rash, fatigue, hepatomegaly and hepatic synthetic dysfunction, biopsy showing fat in stellate cells and fibrosis; little evidence that isotretinoin causes liver injury other than mild rapidly reversible ALT elevations; etretinate causes ALT elevations in ~20% of patients and case reports of clinically apparent injury have been published, but vary in clinical patterns).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">2103414</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.marhold.1991.580">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Marhold</surname>
                  <given-names>I</given-names>
                </name>
                <name name-style="western">
                  <surname>Duschet</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Schwarz</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Gschnait</surname>
                  <given-names>F.</given-names>
                </name>
              </person-group>
              <comment>[Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis]</comment>
              <source>Hautarzt</source>
              <year>1991</year>
              <volume>42</volume>
              <fpage>580</fpage>
              <lpage>3</lpage>
              <comment>German.</comment>
              <annotation>
                <p>
                  <italic toggle="yes">(29 year old woman with psoriasis responded to etretinate but developed rising Alk P levels [172 to 1736 U/L] without jaundice and only mild ALT increases [38 to 178 U/L] 24 days after starting therapy, which improved on stopping and she later tolerated isotretinoin without recurrence [Alk P 118 U/L, ALT 14 U/L]).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">1938411</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.taylor.1991.505">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Taylor</surname>
                  <given-names>AE</given-names>
                </name>
                <name name-style="western">
                  <surname>Mitchison</surname>
                  <given-names>H</given-names>
                </name>
              </person-group>
              <article-title>Fatty liver following isotretinoin therapy.</article-title>
              <source>Br J Dermatol</source>
              <year>1991</year>
              <volume>124</volume>
              <fpage>505</fpage>
              <lpage>6</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(18 year old male body builder developed elevated ALT levels [134 U/L] without jaundice during 6 month course of isotretinoin for acne; liver biopsy showed marked steatosis, but ALT levels remained high 20 months after stopping drug).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">2039732</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.mcelwee.1991.341">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>McElwee</surname>
                  <given-names>NE</given-names>
                </name>
                <name name-style="western">
                  <surname>Schumacher</surname>
                  <given-names>MC</given-names>
                </name>
                <name name-style="western">
                  <surname>Johnson</surname>
                  <given-names>SC</given-names>
                </name>
                <name name-style="western">
                  <surname>Weir</surname>
                  <given-names>TW</given-names>
                </name>
                <name name-style="western">
                  <surname>Greene</surname>
                  <given-names>SL</given-names>
                </name>
                <name name-style="western">
                  <surname>Scotvold</surname>
                  <given-names>MJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Hunter</surname>
                  <given-names>JR</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>An observational study of isotretinoin recipients treated for acne in a health maintenance organization.</article-title>
              <source>Arch Dermatol</source>
              <year>1991</year>
              <volume>127</volume>
              <fpage>341</fpage>
              <lpage>6</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Retrospective analysis of 466 patients treated with isotretinoin in a health care maintenance organization found 6 [1.8%] with moderate AST elevations [90-350 U/L], but levels often normalized despite drug continuation; isotretinoin stopped in 3 patients for liver tests abnormalities).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">1825596</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.vahlquist.1992.s29">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Vahlquist</surname>
                  <given-names>A.</given-names>
                </name>
              </person-group>
              <article-title>Long-term safety of retinoid therapy.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>1992</year>
              <volume>27</volume>
              <issue>6 Pt 2</issue>
              <fpage>S29</fpage>
              <lpage>33</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Patients have been treated with retinoids for up to 15 years, generally without toxicity; retinoids do not accumulate in the liver and do not cause accumulation of fat droplets in stellate cells as occurs with hypervitaminosis A; two types of hepatotoxicity, one idiosyncratic acute hepatitis typically occurring with aromatic retinoids and one a long term low grade injury that can lead to cirrhosis, perhaps aggravated by alcohol that the author claims can occur with all retinoids).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">1460122</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.barth.1993.704">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Barth</surname>
                  <given-names>JH</given-names>
                </name>
                <name name-style="western">
                  <surname>Macdonald-Hull</surname>
                  <given-names>SP</given-names>
                </name>
                <name name-style="western">
                  <surname>Mark</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Jones</surname>
                  <given-names>RG</given-names>
                </name>
                <name name-style="western">
                  <surname>Cunliffe</surname>
                  <given-names>WJ</given-names>
                </name>
              </person-group>
              <article-title>Isotretinoin therapy for acne vulgaris: a re-evaluation of the need for measurements of plasma lipids and liver function tests.</article-title>
              <source>Br J Dermatol</source>
              <year>1993</year>
              <volume>129</volume>
              <fpage>704</fpage>
              <lpage>7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Retrospective analysis of 209 patients treated with isotretinoin found "no significant change in any of the tests of liver function", which led the authors to argue against the recommendation for routine monitoring of liver tests during therapy).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">8286255</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.gunston.1998.1394">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Gunston</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Mehta</surname>
                  <given-names>U</given-names>
                </name>
                <name name-style="western">
                  <surname>van de Wal</surname>
                  <given-names>B</given-names>
                </name>
              </person-group>
              <article-title>New warnings on the use of isotretinoin (Roaccutane).</article-title>
              <source>S Afr Med J</source>
              <year>1998</year>
              <volume>88</volume>
              <fpage>1394</fpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Summary of warnings placed on isotretinoin regarding suicide and potential of liver test abnormalities; 15% of patients on therapy had some degree of liver test abnormality arising on therapy, mostly asymptomatic and resolving without altering dose).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">9861942</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.mawson.2001.734">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Mawson</surname>
                  <given-names>AR</given-names>
                </name>
                <name name-style="western">
                  <surname>Steele</surname>
                  <given-names>TA</given-names>
                </name>
              </person-group>
              <article-title>Possible role of retinoids in hepatitis B virus-associated liver damage.</article-title>
              <source>Exp Biol Med (Maywood)</source>
              <year>2001</year>
              <volume>226</volume>
              <fpage>734</fpage>
              <lpage>9</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review and hypothesis regarding interactions of vitamin A, retinoids and hepatitis B virus infection).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">11520938</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.mclane.2001.s188">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>McLane</surname>
                  <given-names>J.</given-names>
                </name>
              </person-group>
              <article-title>Analysis of common side effects of isotretinoin.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>2001</year>
              <volume>45</volume>
              <fpage>S188</fpage>
              <lpage>94</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Prospective analysis of safety in two trials of isotretinoin in 369 patients with acne found no overall change in mean ALT levels "to a significant extent" and no episodes of hepatitis and jaundice; no mention of drug discontinuation for ALT elevations).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">11606952</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.alcalay.2001.9">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Alcalay</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Landau</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Zucker</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Analysis of laboratory data in acne patients treated with isotretinoin: is there really a need to perform routine laboratory tests?</article-title>
              <source>J Dermatolog Treat</source>
              <year>2001</year>
              <volume>12</volume>
              <fpage>9</fpage>
              <lpage>12</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Retrospective analysis of computerized medical files from 1292 patients treated with isotretinoin for 5 to 9 months, found no patient who required discontinuation because of liver tests; elevations occurred in a "minority of patients", with peak ALT levels of 40-240 U/L).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">12171680</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.charakida.2004.119">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Charakida</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Mouser</surname>
                  <given-names>PE</given-names>
                </name>
                <name name-style="western">
                  <surname>Chu</surname>
                  <given-names>AC</given-names>
                </name>
              </person-group>
              <article-title>Safety and side effects of the acne drug, oral isotretinoin.</article-title>
              <source>Expert Opin Drug Saf</source>
              <year>2004</year>
              <volume>3</volume>
              <fpage>119</fpage>
              <lpage>29</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of myriad of toxicities of isotretinoin from clinical trials: approximately 15% of patients have mild-to-moderate liver test abnormalities, although frank hepatotoxicity is "a fairly rare event").</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">15006718</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.amichai.2006.644">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Amichai</surname>
                  <given-names>B</given-names>
                </name>
                <name name-style="western">
                  <surname>Shemer</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Grunwald</surname>
                  <given-names>MH</given-names>
                </name>
              </person-group>
              <article-title>Low-dose isotretinoin in the treatment of acne vulgaris.</article-title>
              <source>J Am Acad Dermatol</source>
              <year>2006</year>
              <volume>54</volume>
              <fpage>644</fpage>
              <lpage>6</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 638 patients with moderate acne treated with isotretinoin, improvement in &#x0003e;90%; 5% had ALT elevations [all less than 2 times ULN]; no mention of jaundice, symptomatic hepatitis or dose modification because of liver test abnormalities).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">16546586</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.chalasani.2008.1924">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Chalasani</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Fontana</surname>
                  <given-names>RJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonkovsky</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Watkins</surname>
                  <given-names>PB</given-names>
                </name>
                <name name-style="western">
                  <surname>Davern</surname>
                  <given-names>T</given-names>
                </name>
                <name name-style="western">
                  <surname>Serrano</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Yang</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Rochon</surname>
                  <given-names>J</given-names>
                </name>
                <collab>Drug Induced Liver Injury Network (DILIN)</collab>
              </person-group>
              <article-title>Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States.</article-title>
              <source>Gastroenterology</source>
              <year>2008</year>
              <volume>135</volume>
              <fpage>1924</fpage>
              <lpage>34</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 300 cases of drug induced liver disease in the US collected between 2004 and 2008, one was attributed to acitretin: Case 1 for acitretin).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">18955056</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.ferrajolo.2010.721">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ferrajolo</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Capuano</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Verhamme</surname>
                  <given-names>KM</given-names>
                </name>
                <name name-style="western">
                  <surname>Schuemie</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Rossi</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Stricker</surname>
                  <given-names>BH</given-names>
                </name>
                <name name-style="western">
                  <surname>Sturkenboom</surname>
                  <given-names>MC</given-names>
                </name>
              </person-group>
              <article-title>Drug-induced hepatic injury in children: a case/non-case study of suspected adverse drug reactions in VigiBase.</article-title>
              <source>Br J Clin Pharmacol</source>
              <year>2010</year>
              <volume>70</volume>
              <fpage>721</fpage>
              <lpage>8</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Worldwide pharmacovigilance database contained 9036 hepatic adverse drug reactions in children, isotretinoin was the most frequently mentioned agent [420 cases: 6.4%], but no information on the characteristics of the cases is provided).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">21039766</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.devarbhavi.2010.2396">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Devarbhavi</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Dierkhising</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Kremers</surname>
                  <given-names>WK</given-names>
                </name>
                <name name-style="western">
                  <surname>Sandeep</surname>
                  <given-names>MS</given-names>
                </name>
                <name name-style="western">
                  <surname>Karanth</surname>
                  <given-names>D</given-names>
                </name>
                <name name-style="western">
                  <surname>Adarsh</surname>
                  <given-names>CK</given-names>
                </name>
              </person-group>
              <article-title>Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.</article-title>
              <source>Am J Gastroenterol</source>
              <year>2010</year>
              <volume>105</volume>
              <fpage>2396</fpage>
              <lpage>404</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 313 cases of drug induced liver injury seen between 1997 and 2008 at a large hospital in Bangalore, India, no cases were attributed to vitamin A or retinoids).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">20648003</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.reuben.2010.2065">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Reuben</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Koch</surname>
                  <given-names>DG</given-names>
                </name>
                <name name-style="western">
                  <surname>Lee</surname>
                  <given-names>WM</given-names>
                </name>
                <collab>Acute Liver Failure Study Group</collab>
              </person-group>
              <article-title>Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.</article-title>
              <source>Hepatology</source>
              <year>2010</year>
              <volume>52</volume>
              <fpage>2065</fpage>
              <lpage>76</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 1198 patients with acute liver failure enrolled in a US prospective study between 1998 and 2007, 133 were attributed to drug induced liver injury, but none were attributed to vitamin A or a retinoid).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">20949552</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.stickel.2011.595">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Stickel</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>Kessebohm</surname>
                  <given-names>K</given-names>
                </name>
                <name name-style="western">
                  <surname>Weimann</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Seitz</surname>
                  <given-names>HK</given-names>
                </name>
              </person-group>
              <article-title>Review of liver injury associated with dietary supplements.</article-title>
              <source>Liver Int</source>
              <year>2011</year>
              <volume>31</volume>
              <fpage>595</fpage>
              <lpage>605</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of the hepatotoxicity of herbals and nutritional supplements including vitamin A, toxic levels being above 50,000 IU daily, but toxic dose is lower in persons with risk factors such as underlying liver disease).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">21457433</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.vieira.2012.382">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Vieira</surname>
                  <given-names>AS</given-names>
                </name>
                <name name-style="western">
                  <surname>Beijamini</surname>
                  <given-names>V</given-names>
                </name>
                <name name-style="western">
                  <surname>Melchiors</surname>
                  <given-names>AC</given-names>
                </name>
              </person-group>
              <article-title>The effect of isotretinoin on triglycerides and liver aminotransferases.</article-title>
              <source>An Bras Dermatol</source>
              <year>2012</year>
              <volume>87</volume>
              <fpage>382</fpage>
              <lpage>7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 70 patients treated with isotretinoin for 4-12 months, mean serum ALT levels increased from 18 to 23 U/L, but no mention of clinically apparent liver injury or discontinuations).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">22714752</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.tripathi.2013.39">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Tripathi</surname>
                  <given-names>SV</given-names>
                </name>
                <name name-style="western">
                  <surname>Gustafson</surname>
                  <given-names>CJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Huang</surname>
                  <given-names>KE</given-names>
                </name>
                <name name-style="western">
                  <surname>Feldman</surname>
                  <given-names>SR</given-names>
                </name>
              </person-group>
              <article-title>Side effects of common acne treatments.</article-title>
              <source>Expert Opin Drug Saf</source>
              <year>2013</year>
              <volume>12</volume>
              <fpage>39</fpage>
              <lpage>51</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of side effects of acne treatments including isotretinoin mentioning that it can cause hepatitis, for which reason monitoring of aminotransferase levels is recommended).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">23163336</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.bj_rnsson.2013.1419">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bj&#x000f6;rnsson</surname>
                  <given-names>ES</given-names>
                </name>
                <name name-style="western">
                  <surname>Bergmann</surname>
                  <given-names>OM</given-names>
                </name>
                <name name-style="western">
                  <surname>Bj&#x000f6;rnsson</surname>
                  <given-names>HK</given-names>
                </name>
                <name name-style="western">
                  <surname>Kvaran</surname>
                  <given-names>RB</given-names>
                </name>
                <name name-style="western">
                  <surname>Olafsson</surname>
                  <given-names>S</given-names>
                </name>
              </person-group>
              <article-title>Incidence, presentation and outcomes in patients with drug-induced liver injury in the general population of Iceland.</article-title>
              <source>Gastroenterology</source>
              <year>2013</year>
              <volume>144</volume>
              <fpage>1419</fpage>
              <lpage>25</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(In a population based study of drug induced liver injury from Iceland, 96 cases were identified over a 2 year period, three of which were attributed to isotretinoin [ranking 6th in frequency] all of which were anicteric and only one symptomatic).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">23419359</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.blasiak.2013.1392">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Blasiak</surname>
                  <given-names>RC</given-names>
                </name>
                <name name-style="western">
                  <surname>Stamey</surname>
                  <given-names>CR</given-names>
                </name>
                <name name-style="western">
                  <surname>Burkhart</surname>
                  <given-names>CN</given-names>
                </name>
                <name name-style="western">
                  <surname>Lugo-Somolinos</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Morrell</surname>
                  <given-names>DS</given-names>
                </name>
              </person-group>
              <article-title>High-dose isotretinoin treatment and the rate of retrial, relapse, and adverse effects in patients with acne vulgaris.</article-title>
              <source>JAMA Dermatol</source>
              <year>2013</year>
              <volume>149</volume>
              <fpage>1392</fpage>
              <lpage>8</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 116 patients with severe acne treated with isotretinoin, ALT levels above 105 U/L arose in only 1 patient).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">24173086</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.k_z_lyel.2014.234">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>K&#x00131;z&#x00131;lyel</surname>
                  <given-names>O</given-names>
                </name>
                <name name-style="western">
                  <surname>Metin</surname>
                  <given-names>MS</given-names>
                </name>
                <name name-style="western">
                  <surname>Elmas</surname>
                  <given-names>&#x000d6;F</given-names>
                </name>
                <name name-style="western">
                  <surname>&#x000c7;ay&#x00131;r</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Akta&#x0015f;</surname>
                  <given-names>A</given-names>
                </name>
              </person-group>
              <article-title>Effects of oral isotretinoin on lipids and liver enzymes in acne patients.</article-title>
              <source>Cutis</source>
              <year>2014</year>
              <volume>94</volume>
              <fpage>234</fpage>
              <lpage>8</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(In a retrospective analysis of 320 patients with acne treated with isotretinoin for up to 6 months, average ALT levels increased, but the change was not statistically significant).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25474452</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.fern_ndezcrehuet.2014.e004441">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Fern&#x000e1;ndez-Crehuet</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Fern&#x000e1;ndez-Crehuet</surname>
                  <given-names>JL</given-names>
                </name>
                <name name-style="western">
                  <surname>Allam</surname>
                  <given-names>MF</given-names>
                </name>
                <name name-style="western">
                  <surname>Fern&#x000e1;ndez-Crehuet Navajas</surname>
                  <given-names>R</given-names>
                </name>
              </person-group>
              <article-title>Hepatotoxicity of isotretinoin in patients with acne and Gilbert's syndrome: a comparative study.</article-title>
              <source>BMJ Open</source>
              <year>2014</year>
              <volume>4</volume>
              <elocation-id>e004441</elocation-id>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 37 patients with acne treated with isotretinoin for up to 20 weeks, serum bilirubin and ALT levels did not worsen, bilirubin levels actually falling in 11 patients with Gilbert's syndrome).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">24650805</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.hern_ndez.2014.231">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Hern&#x000e1;ndez</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Bessone</surname>
                  <given-names>F</given-names>
                </name>
                <name name-style="western">
                  <surname>S&#x000e1;nchez</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>di Pace</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Brahm</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Zapata</surname>
                  <given-names>R, A</given-names>
                </name>
                <name name-style="western">
                  <surname>Chirino</surname>
                  <given-names>R</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports.</article-title>
              <source>Ann Hepatol</source>
              <year>2014</year>
              <volume>13</volume>
              <fpage>231</fpage>
              <lpage>9</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Systematic review of literature of drug induced liver injury in Latin American countries published from 1996 to 2012 identified 176 cases, two of which were attributed to retinoids, unclear which ones).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">24552865</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.chalasani.2015.1340">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Chalasani</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Bonkovsky</surname>
                  <given-names>HL</given-names>
                </name>
                <name name-style="western">
                  <surname>Fontana</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Lee</surname>
                  <given-names>W</given-names>
                </name>
                <name name-style="western">
                  <surname>Stolz</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Talwalkar</surname>
                  <given-names>J</given-names>
                </name>
                <name name-style="western">
                  <surname>Reddy</surname>
                  <given-names>KR</given-names>
                </name>
                <etal/>
                <collab>United States Drug Induced Liver Injury Network</collab>
              </person-group>
              <article-title>Features and outcomes of 899 patients with drug-induced liver injury: the DILIN Prospective Study.</article-title>
              <source>Gastroenterology</source>
              <year>2015</year>
              <volume>148</volume>
              <fpage>1340</fpage>
              <lpage>52.e7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 899 cases of drug induced liver injury enrolled in a US prospective study between 2004 and 2013, 3 cases were attributed to acitretin, but none to other retinoids or vitamin A).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25754159</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.homma.2015.15">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Homma</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Otani</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Ishimatsu</surname>
                  <given-names>S.</given-names>
                </name>
              </person-group>
              <article-title>A case report of acute vitamin A intoxication due to ocean perch liver ingestion.</article-title>
              <source>J Emerg Med</source>
              <year>2015</year>
              <volume>49</volume>
              <fpage>15</fpage>
              <lpage>7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(27 year old man developed flushing, headache, nausea and joint pains one day after eating 800 g of ocean perch liver, with normal liver enzymes, but high retinol levels and subsequent facial desquamation).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25850632</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.mengualmoreno.2015.3">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Mengual-Moreno</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Lizarz&#x000e1;bal-Garc&#x000ed;a</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Ruiz-Soler</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Silva-Suarez</surname>
                  <given-names>N</given-names>
                </name>
                <name name-style="western">
                  <surname>Andrade-Bellido</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Lucena-Gonz&#x000e1;lez</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Bessone</surname>
                  <given-names>F</given-names>
                </name>
                <etal/>
              </person-group>
              <comment>[Case reports of drug-induced liver injury in a reference hospital of Zulia state, Venezuela]</comment>
              <source>Invest Clin</source>
              <year>2015</year>
              <volume>56</volume>
              <fpage>3</fpage>
              <lpage>12</lpage>
              <comment>Spanish.</comment>
              <annotation>
                <p>
                  <italic toggle="yes">(During a one year period, 13 cases of drug induced liver injury were seen at a single hospital in Venezuela, the implicated agents being acetaminophen [3], ibuprofen [3], isoniazid [2], Herbalife products [2: one fatal], and 1 each of isotretinoin, amoxicillin/clavulanate and methotrexate).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25920181</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.ahmad.2015.151">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Ahmad</surname>
                  <given-names>HM</given-names>
                </name>
              </person-group>
              <article-title>Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.</article-title>
              <source>Dermatol Ther</source>
              <year>2015</year>
              <volume>28</volume>
              <fpage>151</fpage>
              <lpage>7</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 58 patients with acne treated with isotretinoin for an average of 22 weeks, ALT levels increased by 21% with once daily and 3% with twice daily administration of the same average dose, but all elevations were transient and less than 100 U/L).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">25754162</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.bugdayci.2016.213">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bugdayci</surname>
                  <given-names>G</given-names>
                </name>
                <name name-style="western">
                  <surname>Polat</surname>
                  <given-names>M</given-names>
                </name>
                <name name-style="western">
                  <surname>Oguzman</surname>
                  <given-names>H</given-names>
                </name>
                <name name-style="western">
                  <surname>Cinpolat</surname>
                  <given-names>HY</given-names>
                </name>
              </person-group>
              <article-title>Interpretation of biochemical tests using the reference change value in monitoring adverse effects of oral isotretinoin in 102 ethnic Turkish patients.</article-title>
              <source>Lab Med</source>
              <year>2016</year>
              <volume>47</volume>
              <fpage>213</fpage>
              <lpage>9</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Among 102 Turkish patients with acne, ages 15 to 37 years, treated with oral isotretinoin for 24 weeks, mean ALT and AST values did not change, but instances of "Reference Change Values" were more frequent than in controls).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">27346869</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.guzman_rojas.2016.86">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Guzman Rojas</surname>
                  <given-names>P</given-names>
                </name>
                <name name-style="western">
                  <surname>Gallegos Lopez</surname>
                  <given-names>R</given-names>
                </name>
                <name name-style="western">
                  <surname>Ciliotta Chehade</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Scavino</surname>
                  <given-names>Y</given-names>
                </name>
                <name name-style="western">
                  <surname>Morales</surname>
                  <given-names>A</given-names>
                </name>
                <name name-style="western">
                  <surname>Tagle</surname>
                  <given-names>M.</given-names>
                </name>
              </person-group>
              <comment>[Autoimmune hepatitis induced by isotretionine]</comment>
              <source>Rev Gastroenterol Peru.</source>
              <year>2016</year>
              <volume>36</volume>
              <fpage>86</fpage>
              <lpage>9</lpage>
              <comment>Spanish.</comment>
              <annotation>
                <p>
                  <italic toggle="yes">(16 year old girl with acne developed serum enzyme elevations 3 months after starting isotretinoin [ALT 1196 U/L, Alk P 114, ANA 1:180] and improved with stopping isotretinoin and starting corticosteroid therapy).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">27131947</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.deklotz.2017.e20152940">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>DeKlotz</surname>
                  <given-names>CMC</given-names>
                </name>
                <name name-style="western">
                  <surname>Roby</surname>
                  <given-names>KD</given-names>
                </name>
                <name name-style="western">
                  <surname>Friedlander</surname>
                  <given-names>SF</given-names>
                </name>
              </person-group>
              <article-title>Dietary supplements, isotretinoin, and liver toxicity in adolescents: a retrospective case series.</article-title>
              <source>Pediatrics</source>
              <year>2017</year>
              <volume>140</volume>
              <comment>pii</comment>
              <elocation-id>e20152940</elocation-id>
              <annotation>
                <p>
                  <italic toggle="yes">(Eight adolescents with acne in an isotretinoin monitoring program were found to have mild elevations in serum aminotransferase levels [ALT 34-59 U/L, AST 41-187 U/L, bilirubin normal and Alk P not provided], but all were also taking herbal and dietary supplements, including green tea, energy shakes and amino acids and creatine, and the elevations appeared to be more related to these products than the isotretinoin therapy).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">28864554</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.fox.2019">
            <mixed-citation publication-type="other">Fox R, Stace N, Wood K, French C. Liver toxicity from vitamin A. JGH Open 2019; 4: 287-8.<annotation><p><italic toggle="yes">(27 year old female with acne who had received several six-month courses of isotretinoin in the past developed fatigue 18 months after starting vitamin A [bilirubin 0.9 mg/dL, ALT 15 U/L, Alk P 208 U/L], biopsy showing microvesicular fat and prominent stellate cells, with slow improvement after stopping).</italic></p></annotation></mixed-citation>
          </ref>
          <ref id="Isotretinoin.REF.nazarian.2019.9270827">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Nazarian</surname>
                  <given-names>RS</given-names>
                </name>
                <name name-style="western">
                  <surname>Zheng</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Halverstam</surname>
                  <given-names>C</given-names>
                </name>
                <name name-style="western">
                  <surname>Cohen</surname>
                  <given-names>SR</given-names>
                </name>
                <name name-style="western">
                  <surname>Wolkoff</surname>
                  <given-names>AW</given-names>
                </name>
              </person-group>
              <article-title>Prolonged serum alanine aminotransferase elevation associated with isotretinoin administration.</article-title>
              <source>Case Reports Hepatol</source>
              <year>2019</year>
              <volume>2019</volume>
              <elocation-id>9270827</elocation-id>
              <annotation>
                <p>
                  <italic toggle="yes">(16 year old teenage boy developed ALT elevations within 2 months of starting isotretinoin which continued to rise for the month after stopping [peak bilirubin 0.5 mg/dL, ALT 288 U/L, Alk P 153 U/L, INR 1.2], which improved on starting cholestyramine and eventually fell to baseline two months later; he later tolerated restarting isotretinoin without recurrence of liver injury).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">31380129</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.barbieri.2020.21">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Barbieri</surname>
                  <given-names>JS</given-names>
                </name>
                <name name-style="western">
                  <surname>Frieden</surname>
                  <given-names>IJ</given-names>
                </name>
                <name name-style="western">
                  <surname>Nagler</surname>
                  <given-names>AR</given-names>
                </name>
              </person-group>
              <article-title>Isotretinoin, patient safety, and patient-centered care-time to reform iPLEDGE.</article-title>
              <source>JAMA Dermatol</source>
              <year>2020</year>
              <volume>156</volume>
              <fpage>21</fpage>
              <lpage>2</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Viewpoint on the FDA program restricting use of isotretinoin and requiring rigorous monitoring for birth control mentions that pregnancy prevention programs are often ineffective but can be financially burdensome and interfere with appropriate therapy of severe acne; no discussion of ALT elevations or hepatotoxicity).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">31664426</pub-id>
            </element-citation>
          </ref>
          <ref id="Isotretinoin.REF.bagatin.2020.885">
            <element-citation publication-type="journal">
              <person-group>
                <name name-style="western">
                  <surname>Bagatin</surname>
                  <given-names>E</given-names>
                </name>
                <name name-style="western">
                  <surname>Costa</surname>
                  <given-names>CS</given-names>
                </name>
              </person-group>
              <article-title>The use of isotretinoin for acne - an update on optimal dosing, surveillance, and adverse effects.</article-title>
              <source>Expert Rev Clin Pharmacol</source>
              <year>2020</year>
              <volume>13</volume>
              <fpage>885</fpage>
              <lpage>97</lpage>
              <annotation>
                <p>
                  <italic toggle="yes">(Review of the literature on the efficacy and safety of isotretinoin concludes that it is highly effective in patients with severe acne and that its serious side effects can be effectively managed; ALT elevations generally arise during the first few months of therapy and often resolve even without discontinuation or dose modification).</italic>
                </p>
              </annotation>
              <pub-id pub-id-type="pmid">32744074</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
      <sec sec-type="link-group" id="Isotretinoin.OTHER_REFERENCE_LINKS">
        <title>OTHER REFERENCE LINKS</title>
        <list list-type="order">
          <list-item>
            <label>1</label>
            <p>
              <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/sites/entrez?cmd=search&#x00026;db=pubmed&#x00026;pubmedfilters=true&#x00026;term=(Isotretinoin/AE)+AND+Human%5BMH%5D+AND+(drug+induced+liver+injury+OR+jaundice/CI+OR+bile+duct+diseases/CI+OR+liver/DE+OR+liver+diseases/CI)+AND+(%221900/1/1%22%5BEDat%5D:%222999/12/31%22%5BEDat%5D)">Recent References on Isotretinoin: from PubMed.gov</ext-link>
            </p>
          </list-item>
          <list-item>
            <label>2</label>
            <p>
              <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/results?term=Isotretinoin">Trials on Isotretinoin: from ClinicalTrials.gov</ext-link>
            </p>
          </list-item>
        </list>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
